Explore

Trendline Trendline
Varda Space Industries Partners with United Therapeutics for Space-Based Drug Development

Varda Space Industries Partners with United Therapeutics for Space-Based Drug Development

Varda Space Industries Partners with United Therapeutics for Space-Based Drug Development
Trendline Trendline
Exobiosphere and Voyager Technologies Collaborate on ISS Biotech Mission

Exobiosphere and Voyager Technologies Collaborate on ISS Biotech Mission

Exobiosphere and Voyager Technologies Collaborate on ISS Biotech Mission
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Rapid Read Rapid Read
NASA Research on Pneumonia in Space Aims to Improve Heart Health on Earth

NASA Research on Pneumonia in Space Aims to Improve Heart Health on Earth

NASA is conducting research aboard the International Space Station (ISS) to study how bacteria that cause pneumonia can lead to long-term heart damage. The research involves observing how stem cell-derived heart tissues respond to bacterial infections in the unique environment of space. This study is part of the MVP Cell-09 investigation, which aims to uncover new methods for managing cardiovascular health and infectious diseases. In space, bacteria tend to exhibit more severe characteristics and enhanced drug resistance, which researchers are leveraging to better understand cellular responses that are difficult to detect on Earth. The study focuses on the Streptococcus pneumoniae bacteria, a leading cause of community-acquired pneumonia (CAP), which is associated with increased risk of heart disease. The research is crucial for understanding how space-specific factors influence disease progression, which is essential for ensuring human health during long-duration space travel.
Trendline Trendline
Varda Space Industries Partners with United Therapeutics for Drug Development in Microgravity

Varda Space Industries Partners with United Therapeutics for Drug Development in Microgravity

Varda Space Industries Partners with United Therapeutics for Drug Development in Microgravity
Trendline Trendline
Exobiosphere and Voyager Technologies Partner to Advance Space Biotech Research on ISS

Exobiosphere and Voyager Technologies Partner to Advance Space Biotech Research on ISS

Exobiosphere and Voyager Technologies Partner to Advance Space Biotech Research on ISS
Rapid Read Rapid Read
NASA Prepares for Busy Week with SpaceX Dragon Arrival and Spacewalk Preparations

NASA Prepares for Busy Week with SpaceX Dragon Arrival and Spacewalk Preparations

NASA is gearing up for a busy week aboard the International Space Station (ISS) with the upcoming arrival of the SpaceX CRS-34 cargo mission. Scheduled to launch from Cape Canaveral Space Force Station, the uncrewed Dragon spacecraft will deliver approximately 6,500 pounds of science experiments, crew supplies, and lab hardware to the ISS. The Expedition 74 crew, including NASA's Jack Hathaway and ESA's Sophie Adenot, will oversee the Dragon's automated docking. The crew will also engage in various scientific and maintenance activities, including preparing for a Roscosmos spacewalk later this month.
Rapid Read Rapid Read
NASA's ODYSSEY Project Studies Bacteria in Space and Simulated Microgravity

NASA's ODYSSEY Project Studies Bacteria in Space and Simulated Microgravity

NASA's ODYSSEY project, led by Camilla Urbaniak at the Jet Propulsion Laboratory, is investigating how bacteria behave in microgravity. The study focuses on two bacterial species to understand their growth, biofilm formation, and genetic material exchange in space. Experiments are conducted both on the International Space Station and in Earth-based microgravity simulators to compare results. This research aims to enhance the success of future space missions and develop strategies to control infections in hospitals on Earth.
Trendline Trendline
BeOne Medicines Honored as 'Outstanding Global Oncology Company' for Advancements in Cancer Therapies

BeOne Medicines Honored as 'Outstanding Global Oncology Company' for Advancements in Cancer Therapies

BeOne Medicines Honored as 'Outstanding Global Oncology Company' for Advancements in Cancer Therapies
Rapid Read Rapid Read
NASA's Artemis 2 Astronauts Gain New Insights on Lunar Surface Through Unique Observations

NASA's Artemis 2 Astronauts Gain New Insights on Lunar Surface Through Unique Observations

NASA's Artemis 2 mission provided astronauts with a rare opportunity to observe the moon's far side, a view not seen by humans in over 50 years. The mission, which took place in early April, involved a team of four astronauts who were trained by NASA's lunar scientists to identify and document various geological features on the moon. The astronauts used a Lunar Science Passport, a guide that helped them focus on key observation targets, known as the 'Big Fifteen.' These targets included diverse geological formations that could provide answers to significant scientific questions. The mission emphasized the importance of human observation, as astronauts were able to perceive colors and textures that robotic explorers might miss. This human element allowed for a more nuanced understanding of the moon's surface, contributing valuable data to NASA's ongoing lunar research.
Rapid Read Rapid Read
NASA Investigates Bacterial Behavior in Space to Enhance Future Missions

NASA Investigates Bacterial Behavior in Space to Enhance Future Missions

NASA's ODYSSEY project is examining how bacteria behave in microgravity environments, with experiments conducted both aboard the International Space Station and in Earth-based microgravity simulators. The research focuses on two bacterial species to understand their growth, biofilm formation, and genetic material exchange in space. This study aims to improve the success of future space missions and develop strategies to control infections in hospitals on Earth. The project is led by Camilla Urbaniak from NASA's Jet Propulsion Laboratory.
Trendline Trendline
AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials